Rjs Biologics L L C is categorized under Research and Development Laboratories in Seattle, WA and active since 2009.
Rjs Biologics L L C was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Stephen Mccraith Phd at the company’s single location by writing to 3049 Ne 95th St, Seattle, Washington WA 98115 or by phoning (206) 517-5068. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Rjs Biologics L L C |
| Contact Person: | Stephen Mccraith Phd |
| Address: | 3049 Ne 95th St, Seattle, Washington 98115 |
| Phone Number: | (206) 517-5068 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Rjs Biologics L L C was started in 2009 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Stephen Mccraith Phd for inquiries that concern Rjs Biologics L L C by calling the company number (206) 517-5068, as your correspondence is most welcome. Additionally, the physical location of the single location of Rjs Biologics L L C can be found at the coordinates 47.697369,-122.293822 as well as the street address 3049 Ne 95th St in Seattle, Washington 98115.
For its online presence, you may visit Rjs Biologics L L C’s website at and engage with its social media outlets through on Twitter and on Facebook.